Rachman Ilya M 4
4 · Immix Biopharma, Inc. · Filed Sep 17, 2025
Insider Transaction Report
Form 4
Rachman Ilya M
DirectorCEO and Chairman
Transactions
- Purchase
Common Stock
2025-09-17$2.02/sh+2,500$5,050→ 1,140,937 total
Footnotes (1)
- [F1]Volume-weighted average price of purchases which transactions occurred at purchase prices from $2.01 to $2.02 per share, inclusive. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.